Paper: Optimization of the development of Inhalable EGCG nano-Liposome as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of Design of Experiments Approach
I am Fatma Haddad, I was born and raised in Palestine. I grew up with a passion for research.
In 2013, I was awarded a BSc degree in pharmacy from An-Najah National University, Nablus, Palestine. Since 2015, I have worked as a pharmacist for the Palestinian Ministry of Health's primary healthcare centers in south Hebron. In 2018, I completed an MSc course in pharmaceutical science from Al-Quds University, Palestine ranking in 1st place among the year’s 685 graduate students from Graduate studies with an average of 96.3%. From 2016-2019, I worked as a researcher in the drug development and design laboratory of the faculty of pharmacy at Al-Quds University. In 2020, I had the best MSc thesis award in pharmacy college from Al-Quds university. In 2020, I had the award for the most active research group (Drug development and design group under professor Rafik Karaman’s supervision at Al-Quds university).
Currently, I am doing my Ph.D., at the School of Pharmacy and Medical Science, at the University of Bradford, Bradford, UK, under the supervision of Dr. Khaled Assi.
My Ph.D. research focuses on the development of formulations suitable for inhalation such as nano-liposome, nano-emulsion, and nanoparticles (Drug delivery to the lung for the potential treatment of lung cancer and pulmonary hypertension).